13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13D/A Filed 2026-08-17 Event 2026-08-13 SEC 0001072613-26-000694 →

SR ONE CAPITAL MANAGEMENT, LLC Zenas BioPharma, Inc. ZBIO

Stake: Shares: 5,037,854 Class: Common stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
24 transactions
24 buys · 0 sales · 0 awards/exercises
Issuer Cluster
3 13D/G filings on this issuer
2 other filings besides this one
Filer Track Record
7 filings by this filer
6 other filings in the data moat
Short Interest · settle 2026-07-31
DTC 13.83
11,753,566 shares short · -3.4% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers
1 holder · $10.48M
Point72 Asset Mgmt

Form 4 Insider Transactions · last 365d

DateInsiderRoleTypeSharesPriceValue
2026-04-29 MOULDER LEON O JR director, officer Buy 35,000 $17.62 $617K
2026-04-28 MOULDER LEON O JR director, officer Buy 25,000 $18.02 $451K
2026-03-31 Lu Hongbo director Buy 3,768 $18.63 $70K
2026-03-31 Fairmount Funds Management LLC director Buy 150,000 $20.00 $3.00M
2026-03-31 Lu Hongbo director Buy 75,000 $20.00 $1.50M
2026-03-31 MOULDER LEON O JR director, officer Buy 34,000 $19.31 $657K
2026-03-30 MOULDER LEON O JR director, officer Buy 20,000 $18.23 $365K
2026-02-13 Allen Patricia L director Buy 4,160 $26.36 $110K
2026-02-12 Allen Patricia L director Buy 5,000 $23.77 $119K
2026-02-12 Allen Patricia L director Buy 5,700 $24.34 $139K
2026-02-12 Allen Patricia L director Buy 5,000 $26.50 $133K
2026-02-11 Lu Hongbo director Buy 25,985 $22.50 $585K
2026-02-02 MOULDER LEON O JR director, officer Buy 57,000 $17.96 $1.02M
2026-01-09 MOULDER LEON O JR director, officer Buy 20,000 $16.55 $331K
2026-01-08 MOULDER LEON O JR director, officer Buy 30,000 $16.30 $489K
2026-01-07 MOULDER LEON O JR director, officer Buy 50,000 $16.38 $819K
2025-10-09 Nunn Jason Raleigh director Buy 63,158 $19.00 $1.20M
2025-10-09 SR ONE CAPITAL MANAGEMENT, LLC 10%+ owner Buy 63,158 $19.00 $1.20M
2025-10-09 ENRIGHT PATRICK G director Buy 105,265 $19.00 $2.00M
2025-10-09 ENRIGHT PATRICK G director Buy 11,990 $20.85 $250K
2025-10-09 SR ONE CAPITAL MANAGEMENT, LLC 10%+ owner Buy 63,157 $19.00 $1.20M
2025-10-07 MOULDER LEON O JR director, officer Buy 36,928 $20.85 $770K
2025-10-07 Fairmount Funds Management LLC director Buy 316,219 $19.00 $6.01M
2025-10-07 Lu Hongbo director Buy 263,160 $19.00 $5.00M

Other 13D/G Filings on Zenas BioPharma, Inc.

FiledFormFilerStakeShares
2026-08-19 SCHEDULE 13D/A Enavate Sciences GP, LLC 4.90% 3,245,404 view →
2025-10-14 SCHEDULE Enavate Sciences GP, LLC 7.30% 3,919,159 view →

Other Filings by SR ONE CAPITAL MANAGEMENT, LLC

FiledFormIssuerStakeShares
2026-08-14 SCHEDULE 13D/A Veradermics, Inc. 2,080,119 view →
2026-05-18 SCHEDULE 13D Odyssey Therapeutics, Inc. ODTX 8.00% 3,794,883 view →
2025-10-01 SCHEDULE KALA BIO, Inc. KALA 5.50% 411,000 view →
2023-12-18 SC Arcellx, Inc. ACLX view →
2023-06-02 SC Arcellx, Inc. ACLX view →
2022-06-27 SC Arcellx, Inc. ACLX view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →